275 related articles for article (PubMed ID: 32170926)
21. Genetic basis of familial valvular heart disease.
Padang R; Bagnall RD; Semsarian C
Circ Cardiovasc Genet; 2012 Oct; 5(5):569-80. PubMed ID: 23074336
[No Abstract] [Full Text] [Related]
22. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.
Caira FC; Stock SR; Gleason TG; McGee EC; Huang J; Bonow RO; Spelsberg TC; McCarthy PM; Rahimtoola SH; Rajamannan NM
J Am Coll Cardiol; 2006 Apr; 47(8):1707-12. PubMed ID: 16631011
[TBL] [Abstract][Full Text] [Related]
23. Epicardial deletion of Sox9 leads to myxomatous valve degeneration and identifies Cd109 as a novel gene associated with valve development.
Harvey AB; Wolters RA; Deepe RN; Tarolli HG; Drummond JR; Trouten A; Zandi A; Barth JL; Mukherjee R; Romeo MJ; Vaena SG; Tao G; Muise-Helmericks R; Ramos PS; Norris RA; Wessels A
J Mol Cell Cardiol; 2024 Jan; 186():16-30. PubMed ID: 37935281
[TBL] [Abstract][Full Text] [Related]
24. [Biopsy of the heart valves. 872 cases].
Steiner I; Dominik J
Cesk Patol; 2000 Jan; 36(1):15-20. PubMed ID: 10838753
[TBL] [Abstract][Full Text] [Related]
25. Conserved transcriptional regulatory mechanisms in aortic valve development and disease.
Wirrig EE; Yutzey KE
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):737-41. PubMed ID: 24665126
[TBL] [Abstract][Full Text] [Related]
26. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
[TBL] [Abstract][Full Text] [Related]
27. Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.
Thalji NM; Hagler MA; Zhang H; Casaclang-Verzosa G; Nair AA; Suri RM; Miller JD
Circ Cardiovasc Genet; 2015 Jun; 8(3):516-28. PubMed ID: 25814644
[TBL] [Abstract][Full Text] [Related]
28. High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase.
Chang FJ; Yuan HY; Hu XX; Ou ZJ; Fu L; Lin ZB; Wang ZP; Wang SM; Zhou L; Xu YQ; Wang CP; Xu Z; Zhang X; Zhang CX; Ou JS
J Mol Cell Cardiol; 2014 Sep; 74():209-19. PubMed ID: 24887036
[TBL] [Abstract][Full Text] [Related]
29. Echocardiographic determination of the prevalence of primary myxomatous degeneration of the cardiac valves.
He Y; Guo Y; Li Z; Chen J; Kontos MC; Paulsen WH; Han J; Wang L; Gu X; Nixon JV
J Am Soc Echocardiogr; 2011 Apr; 24(4):399-404. PubMed ID: 21353473
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of amyloid in 150 surgically removed heart valves--a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions.
Kristen AV; Schnabel PA; Winter B; Helmke BM; Longerich T; Hardt S; Koch A; Sack FU; Katus HA; Linke RP; Dengler TJ
Cardiovasc Pathol; 2010; 19(4):228-35. PubMed ID: 19502085
[TBL] [Abstract][Full Text] [Related]
31. Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.
Dupuis LE; McCulloch DR; McGarity JD; Bahan A; Wessels A; Weber D; Diminich AM; Nelson CM; Apte SS; Kern CB
Dev Biol; 2011 Sep; 357(1):152-64. PubMed ID: 21749862
[TBL] [Abstract][Full Text] [Related]
32. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.
Disatian S; Ehrhart EJ; Zimmerman S; Orton EC
J Heart Valve Dis; 2008 Jul; 17(4):402-11; discussion 412. PubMed ID: 18751470
[TBL] [Abstract][Full Text] [Related]
33. Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha.
Ghosh S; Hoenerhoff MJ; Clayton N; Myers P; Stumpo DJ; Maronpot RR; Blackshear PJ
Am J Pathol; 2010 Mar; 176(3):1484-93. PubMed ID: 20093488
[TBL] [Abstract][Full Text] [Related]
34. Etiology of valvular heart disease-genetic and developmental origins.
Lincoln J; Garg V
Circ J; 2014; 78(8):1801-7. PubMed ID: 24998280
[TBL] [Abstract][Full Text] [Related]
35. Morphological aspects of valvular heart disease: Part I.
Waller BF
Curr Probl Cardiol; 1984 Oct; 9(7):1-66. PubMed ID: 6488868
[No Abstract] [Full Text] [Related]
36. Citric acid as a decalcifying agent for the excised calcified human heart valves.
Köse N; Aytaçoğlu BN; Yilmaz N; Döndaş HA; Tamer L; Coşkun B; Vezir O; Sucu N; Dikmengil M
Anadolu Kardiyol Derg; 2008 Apr; 8(2):94-8. PubMed ID: 18400627
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms underlying the onset of degenerative aortic valve disease.
Hakuno D; Kimura N; Yoshioka M; Fukuda K
J Mol Med (Berl); 2009 Jan; 87(1):17-24. PubMed ID: 18766323
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of operatively excised cardiac valves: etiologic determination of valvular heart disease.
Waller BF; Bloch T; Barker BG; Roe SJ; Brown JW; Mahomed Y
Cardiol Clin; 1984 Nov; 2(4):687-716. PubMed ID: 6544649
[TBL] [Abstract][Full Text] [Related]
39. LARP7 Suppresses Endothelial-to-Mesenchymal Transition by Coupling With TRIM28.
Liang X; Wu S; Geng Z; Liu L; Zhang S; Wang S; Zhang Y; Huang Y; Zhang B
Circ Res; 2021 Oct; 129(9):843-856. PubMed ID: 34503347
[TBL] [Abstract][Full Text] [Related]
40. Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology.
Porras AM; Shanmuganayagam D; Meudt JJ; Krueger CG; Hacker TA; Rahko PS; Reed JD; Masters KS
J Am Heart Assoc; 2015 Oct; 4(10):e002254. PubMed ID: 26508741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
